NATIVE study: Daily Serum Collection after Acellular Dermal Matrix-Assisted Breast Reconstruction
Daily Serum Collection after Acellular Dermal
Matrix-Assisted Breast Reconstruction
Glenda Giorgia Caputo1, Zeno Franchini2, Monia Maritan1, Edoardo Dalla Pozza1,
Enrico Vigato1, Umberto Tedeschi2, Maurizio Governa1
1Plastic and Reconstructive Surgery, Surgery and Odontology Department, University Hospital of Verona, Verona; 2General Surgery, Surgery
and Odontology Department, University Hospital of Verona, Verona, Italy
The acellular dermal matrix (ADM)-assisted breast reconstruction technique is
widely known, but discouraging results due to early postoperative complications have been
reported. As the literature identifies seroma as the most common issue after breast surgery
without identifying its pathogenesis, we aimed to report the trend of postoperative daily
serum collection after ADM-assisted breast reconstruction and compare it with data in the
literature in order to discover more about this little-known topic.
Methods A retrospective study on 28 consecutive patients who received ADM-assisted
breast reconstruction between February 2013 and February 2014 was performed. In order to
reduce the number of variables that could affect serum production, only one brand of ADM
was used and all tissues were handled gently and precisely. The daily drainage volume was
recorded per patient during the first four days of hospitalization. Likewise, postoperative
complications were noted during routine follow-up.
Results In total, five (17.9%) bilateral and 23 (82.1%) unilateral ADM-assisted breast
reconstructions (33 implants) were performed. The mean age, body mass index, and length of
hospital stay were 53.6 years, 21.3 kg/m2, and 4.5 days, respectively. One major complication
led to implant loss (3.0%), and nine minor complications were successfully treated with
ambulatory surgery (27.3%). Serum collection linearly decreased after 24 hours postoperatively.
Conclusions Daily drainage decreased following the theoretical decline of acute inflammation.
In concordance with the literature, daily serum production may not be related to the use of
Seroma / Acellular dermis / Mammaplasty / Inflammation / Mastectomy